Email

26:I[56264,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js","/_next/static/chunks/2tie5rqwdsi89.js","/_next/static/chunks/2dnipz2c0692b.js","/_next/static/chunks/1mf5iq195c2sn.js","/_next/static/chunks/03wn0-bzh3abk.js","/_next/static/chunks/0_02m0ghanddv.js"],"GuestHistoryRecorder"] 27:I[3004,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js","/_next/static/chunks/2tie5rqwdsi89.js","/_next/static/chunks/2dnipz2c0692b.js","/_next/static/chunks/1mf5iq195c2sn.js","/_next/static/chunks/03wn0-bzh3abk.js","/_next/static/chunks/0_02m0ghanddv.js"],"EmailPreview"] 2a:I[27201,["/_next/static/chunks/3fntmmi971322.js","/_next/static/chunks/1ymt1shyhmu-4.js","/_next/static/chunks/291ciwmgtp_xc.js","/_next/static/chunks/2owa30hnifmhr.js"],"IconMark"] 28:T1436, Email

Hi,

I started Everlywell because I believe people deserve direct, timely access to their own health information.

That belief has always shaped how we think about proactive testing — and why we keep looking for ways to give you more options, not just more products.

Today, we're expanding that work with Caris Detect, a new blood test designed to look for signals of multiple cancers, including cancers that don't have routine screening today.

Recommended cancer screenings like mammograms and colonoscopies are important, but they only screen for a small number of cancers. Most cancers don't have a recommended routine screening at all, which can make them harder to find before symptoms appear.

Caris Detect is designed to help address that gap. It combines whole genome sequencing, whole transcriptome sequencing, and proprietary AI informed by more than 1 million profiled cases to look for cancer signals in the blood and — when a cancer signal is detected — to help identify the likely tissue of origin.

This is what proactive health should look like: more visibility, more options, and more support along the way, so you can make informed decisions with your healthcare provider.

I'm proud of this partnership and about what it means for the future of Everlywell, but I'm even more excited about the potentially life-saving impact that tests like Caris Detect may have.

Learn more about the Caris Detect Multi-Cancer Early Detection Test.

With care,
Julia Cheek
Founder & CEO, Everlywell

Julia Cheek knows firsthand how frustrating it can be to seek answers about your health — only to hit walls of cost, complexity, and waiting. That experience drove her to found Everlywell with a simple belief: there has to be a better way. What started as at-home lab testing has grown into a suite of comprehensive testing options, including Everlywell 360, which goes far beyond the standard annual physical with 83 biomarkers so you can finally see what's affecting how you feel every day, and do something about it.

No longer want to receive these emails? Unsubscribe.

Your purchase may be HSA/FSA eligible. Check with your plan administrator. Everlywell is not responsible for contacting your plan administrator on your behalf.

Everlywell works with a network of licensed clinicians who review your request and order the test. Caris Detect™ Multi-Cancer Early Detection Test is performed by Caris Life Sciences' CLIA-certified, CAP-accredited laboratory. Results are provided to you and made available in your online portal.

Caris Detect does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results may occur. Caris Detect is intended to complement, not replace, recommended cancer screening tests and other medical evaluations, so it is important that you continue recommended cancer screenings and routine preventive healthcare based on your individual risk factors.

Results should be interpreted in conjunction with discussion with your healthcare provider and potential follow-up diagnostic testing. A positive result is not a diagnosis. A negative result does not rule out cancer or mean that an individual will not develop cancer in the future.

29:Te69,Email An update from Julia on how we're expanding proactive testing options. Hi, I started Everlywell because I believe people deserve direct, timely access to their own health information. That belief has always shaped how we think about proactive testing — and why we keep looking for ways to give you more options, not just more products. Today, we're expanding that work with Caris Detect, a new blood test designed to look for signals of multiple cancers, including cancers that don't have routine screening today. Recommended cancer screenings like mammograms and colonoscopies are important, but they only screen for a small number of cancers. Most cancers don't have a recommended routine screening at all, which can make them harder to find before symptoms appear. Caris Detect is designed to help address that gap. It combines whole genome sequencing, whole transcriptome sequencing, and proprietary AI informed by more than 1 million profiled cases to look for cancer signals in the blood and — when a cancer signal is detected — to help identify the likely tissue of origin. This is what proactive health should look like: more visibility, more options, and more support along the way, so you can make informed decisions with your healthcare provider. I'm proud of this partnership and about what it means for the future of Everlywell, but I'm even more excited about the potentially life-saving impact that tests like Caris Detect may have. Learn more about the Caris Detect Multi-Cancer Early Detection Test . With care, Julia Cheek Founder & CEO, Everlywell Julia Cheek knows firsthand how frustrating it can be to seek answers about your health — only to hit walls of cost, complexity, and waiting. That experience drove her to found Everlywell with a simple belief: there has to be a better way. What started as at-home lab testing has grown into a suite of comprehensive testing options, including Everlywell 360, which goes far beyond the standard annual physical with 83 biomarkers so you can finally see what's affecting how you feel every day, and do something about it. No longer want to receive these emails? Unsubscribe . Your purchase may be HSA/FSA eligible. Check with your plan administrator. Everlywell is not responsible for contacting your plan administrator on your behalf. Everlywell works with a network of licensed clinicians who review your request and order the test. Caris Detect™ Multi-Cancer Early Detection Test is performed by Caris Life Sciences' CLIA-certified, CAP-accredited laboratory. Results are provided to you and made available in your online portal. Caris Detect does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results may occur. Caris Detect is intended to complement, not replace, recommended cancer screening tests and other medical evaluations, so it is important that you continue recommended cancer screenings and routine preventive healthcare based on your individual risk factors. Results should be interpreted in conjunction with discussion with your healthcare provider and potential follow-up diagnostic testing. A positive result is not a diagnosis. A negative result does not rule out cancer or mean that an individual will not develop cancer in the future. 1f:["$","article",null,{"className":"min-w-0 flex-1 overflow-hidden","aria-label":"A breakthrough in early cancer detection","children":[["$","$L26",null,{"emailId":"da7d791d-2734-47c1-b6be-afe57684a57a"}],["$","$L27",null,{"email":{"id":"da7d791d-2734-47c1-b6be-afe57684a57a","subject":"A breakthrough in early cancer detection","previewText":"Email An update from Julia on how we're expanding proactive testing options. \nHi,\n\nI started Everlywell because I believe people deserve direct, timely access to \ntheir own health information.\n\nThat belief has always shaped how we think about proactive testing — and why \nwe keep looking for ways to","sentAt":"2026-09-10T18:02:04.000Z","classification":"marketing","imageCount":1,"thumbnailUrl":"https://mailspo-ingest.imraan-243.workers.dev/img/inbound/img/b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b","emailType":"newsletter","typeConfidence":"guess","typeBasis":"no stronger signal","brand":"$24:props:brands:312","bodyHtml":"$28","textBody":"$29","bodyFallback":null}}]]}] a:null f:[["$","title","0",{"children":"A breakthrough in early cancer detection by EverlyWell | Mailspo"}],["$","meta","1",{"name":"description","content":"Email An update from Julia on how we're expanding proactive testing options. \nHi,\n\nI started Everlywell because I believe people deserve direct, timely access t"}],["$","meta","2",{"name":"robots","content":"index, follow"}],["$","link","3",{"rel":"canonical","href":"https://mailspo.com/emails/da7d791d-2734-47c1-b6be-afe57684a57a"}],["$","meta","4",{"property":"og:title","content":"A breakthrough in early cancer detection by EverlyWell | Mailspo"}],["$","meta","5",{"property":"og:description","content":"Email An update from Julia on how we're expanding proactive testing options. \nHi,\n\nI started Everlywell because I believe people deserve direct, timely access t"}],["$","meta","6",{"property":"og:url","content":"https://mailspo.com/emails/da7d791d-2734-47c1-b6be-afe57684a57a"}],["$","meta","7",{"property":"og:site_name","content":"Mailspo"}],["$","meta","8",{"property":"og:image","content":"https://mailspo-ingest.imraan-243.workers.dev/img/inbound/img/b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b"}],["$","meta","9",{"property":"og:image:alt","content":"EverlyWell email creative: A breakthrough in early cancer detection"}],["$","meta","10",{"property":"og:type","content":"article"}],["$","meta","11",{"property":"article:published_time","content":"2026-09-10T18:02:04.000Z"}],["$","meta","12",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","13",{"name":"twitter:title","content":"A breakthrough in early cancer detection by EverlyWell | Mailspo"}],["$","meta","14",{"name":"twitter:description","content":"Email An update from Julia on how we're expanding proactive testing options. \nHi,\n\nI started Everlywell because I believe people deserve direct, timely access t"}],["$","meta","15",{"name":"twitter:image","content":"https://mailspo-ingest.imraan-243.workers.dev/img/inbound/img/b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b"}],["$","meta","16",{"name":"twitter:image:alt","content":"EverlyWell email creative: A breakthrough in early cancer detection"}],["$","link","17",{"rel":"icon","href":"/favicon.ico?favicon.3lxqohtg4uvbd.ico","sizes":"48x48","type":"image/x-icon"}],["$","$L2a","18",{}]]

Search Mailspo